Guo X, Wang A, Chen S, Qiu Z
PUMC Hospital, Beijing.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1997 Aug;19(4):312-4.
To evaluate effects of monoclonal antibody (McAb) against TNFa on E. coli infected mice.
30 mice (10 week old, Kunming) were divided equally into three groups. The first group, as a control, 200 microliters saline (NS)/mouse was injected intravenously; Second group (untreated group), only E. coli (10(7) organisms/200 microliters NS) were injected intra-abdominaly; Third group (treated group), E. coli (10(7) organisms) were injected intra-abdominal and McAb against TNF alpha 2 mg/kg dissolved in 200 microliters NS were injected intravenously. After 24 h, observed the survival rate, compared the serum TNF level in blood and investigated pathology of intestine, lung and liver.
There was a higher survival rate in treated group, with the serum TNF level lowered significantly, and the untreated mice had severe pathologic changes in viscera.
Using anti-TNF alpha McAb was effective in reducing mortality rate in mice after infected with E. coli, but could not prevent the pathologic changes.
评估抗TNFα单克隆抗体对大肠杆菌感染小鼠的影响。
将30只10周龄昆明小鼠平均分为三组。第一组作为对照组,静脉注射200微升生理盐水(NS)/只;第二组(未治疗组),仅腹腔注射大肠杆菌(10⁷个菌/200微升NS);第三组(治疗组),腹腔注射大肠杆菌(10⁷个菌),并静脉注射溶解于200微升NS中的抗TNFα单克隆抗体2毫克/千克。24小时后,观察存活率,比较血液中血清TNF水平,并研究肠道、肺和肝脏的病理学变化。
治疗组存活率较高,血清TNF水平显著降低,未治疗小鼠内脏有严重病理变化。
使用抗TNFα单克隆抗体可有效降低大肠杆菌感染后小鼠的死亡率,但不能预防病理变化。